FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. C & A Naturistics

    C & A Naturistics sold unapproved new drugs online, including AK Forte with hidden acetaminophen and diclofenac.

    High risk
  2. Fox Pharma LLC

    FDA warned Fox Pharma LLC that it sells unapproved injectable lipolytic drugs online.

    High risk
  3. Vivid-Scientific LLC

    Vivid-Scientific LLC sold injectable fat-dissolving products online as unapproved new drugs without FDA-approved applications.

    High risk
  4. Amazon.com, Inc.

    FDA warned Amazon over selling unapproved injectable fat-dissolving drugs on its website.

    High risk
  5. Shree Jaya Laboratories PVT. LTD.

    FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.

    High risk
  6. Linghai ZhanWang Biotechnology Co., Ltd

    Linghai ZhanWang Biotechnology's OTC drugs, including antimicrobial wipes, fail manufacturing quality rules; FDA cites missing tests.

    High risk
  7. Aurora Pharmaceutical

    FDA told Aurora Pharmaceutical its websites and brochures for three animal drugs hid safety warnings, making the products misbranded.

    Medium
  8. Q’Apel Medical, Inc.

    Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.

    High risk
  9. Elanco Animal Health

    FDA says Elanco's Zenrelia promotional materials omit or misstate safety warnings and study results, misbranding the veterinary drug.

    High risk
  10. Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals

    FDA warned outsourcing facility Carie Boyd Pharmaceuticals in Irving, TX that sterile drug production had airflow, media fill and contamination control failures.

    High risk
  11. ProRx, LLC

    FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.

    High risk
  12. Granules India Limited

    FDA warned Granules India in Telangana, India, that its finished drugs are adulterated after inspectors found cross-contamination in air ducts, bird droppings and torn records.

    High risk
  13. TKTX Numb Store

    FDA warned TKTX Numb Store that its lidocaine anesthetic creams are unapproved and misbranded drugs sold without a prescription.

    High risk
  14. TKTX Store

    FDA warns TKTX Store it sells unapproved lidocaine and prilocaine numbing creams online for tattooing and cosmetic procedures.

    High risk
  15. TKTX Numbing Cream USA

    FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.

    High risk
  16. Chem-Tech, Ltd.

    Chem-Tech, Ltd. lacked adequate investigations and clean equipment for its OTC drug.

    High risk
  17. Mariscos Procesados - CAMPRESA - S.A.

    Mariscos Procesados-CAMPRESA's frozen vacuum-packed mahi-mahi fillets lacked required seafood HACCP controls, FDA says.

    High risk
  18. Garcia Fresh Vegetables LLC

    FDA warned Garcia Fresh Vegetables for lacking a Foreign Supplier Verification Program for all imported foods after a December 2024 inspection.

    Medium
  19. Radhaswamy Inc. dba Raja Foods LLC

    FDA warned Radhaswamy Inc. dba Raja Foods that it lacked required foreign supplier verification for most imported foods, including rice and candy.

    High risk
  20. ABR Laboratory LLC

    FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.

    High risk
  21. Tyche Industries Ltd

    FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.

    High risk
  22. Jagsonpal Pharmaceuticals Limited

    Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.

    High risk
  23. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  24. Robbins Instruments, LLC

    Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.

    High risk
  25. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk
  26. Wuhu Nuowei Chemistry Co., Ltd.

    FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.

    High risk
  27. ISOThrive, Inc.

    ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.

    High risk
  28. Strukmyer LLC dba Strukmyer Medical

    Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.

    High risk
  29. Shantou Kangjie Daily Chemical Industry Co., Ltd

    FDA warns Shantou Kangjie over CGMP failures for OTC drugs, including untested ethanol and no quality unit.

    High risk
  30. Imperial Palace Commodity -Dongguan- Co., Ltd.

    FDA warns Chinese maker of OTC alcohol wipes that weak component testing and process validation make its drugs adulterated.

    High risk
  31. Center for Instrumental Analysis of China Pharmaceutical University

    Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.

    High risk
  32. Global Calcium Pvt. Limited

    FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.

    High risk
  33. Talla Imports, LLC

    FDA says Talla Imports lacked required foreign supplier safety plans for Swedish toffee, cookies and candy.

    Medium
  34. Fagron Compounding Services, LLC dba Fagron Sterile Service

    FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.

    High risk
  35. Kardesler Ucan Yaglar Sanayi Anonim Sirketi

    Turkey-based OTC drug maker Kardesler Ucan failed to test glycerin, propylene glycol and ethanol for dangerous impurities and is on US import alert.

    High risk
  36. Chara Biologics, Inc.

    FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.

    High risk
  37. Evolutionary Biologics Inc.

    FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.

    High risk
  38. Sanofi

    FDA warned Sanofi subsidiary Genzyme over manufacturing quality failures at its Framingham, MA API plant.

    High risk
  39. Atlanta Supersource, Inc.

    Atlanta Supersource made OTC hand sanitizers on equipment shared with toxic industrial chemicals and lacked testing, FDA says.

    High risk
  40. COFISA - Conservas de Peixe da Figueira, S.A.

    FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

    High risk
  41. Premium Fresh Growers LLC

    FDA warns Premium Fresh Growers it lacked required foreign supplier checks for imported limes, cilantro, and carrots.

    Medium
  42. Duong Ha Processing Trading Seafood Company Limited

    FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.

    High risk
  43. Salt City Baking Company, LLC

    FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.

    High risk
  44. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  45. Miyajima Shoyu Co., Ltd.

    Miyajima Shoyu lacked FDA-filed scheduled processes for acidified Wasabi Dressing, making it adulterated.

    High risk
  46. By George Food Specialties Inc.

    By George Food Specialties lacked required foreign supplier verification program for imported mayonnaise and hot sauce, FDA says.

    Medium
  47. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.

    High risk
  48. Hologic, Inc.

    FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.

    High risk
  49. Randox Laboratories Limited

    FDA warned Randox Laboratories over inadequate risk analysis and corrective actions for carryover errors in RX series analyzers.

    High risk
  50. Indoco Remedies Limited

    FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.

    High risk